Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

TCR2 THERAPEUTICS INC. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16
Revenues19.79.67.7
            Revenue growth105.6%24.5% 
Cost of goods sold26.513.20.0
Gross profit-6.8-3.67.7
            Gross margin-34.5%-37.7%100.0%
General and administrative6.83.62.3
EBIT-26.5-13.25.4
            EBIT margin-134.5%-137.7%70.6%
Pre-tax income-24.3-13.1-9.9
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income-0.10.00.0
            Net margin-0.3%-0.2%-0.1%
 
Diluted EPS($98.53)($39.94)($38.64)
Shares outstanding (diluted)0.00.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy